Clinical trial
Long-term Follow-up Study of Implantation of the VenusP-Valve™ in the Pulmonic Position in Patients With Native Outflow Tracts
NCT07531303 is registered in ClinicalTrials.gov with Venus MedTech (HangZhou) Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-term Follow-up Study of Implantation of the VenusP-Valve™ in the Pulmonic Position in Patients With Native Outflow Tracts
- Lead sponsor
- Venus MedTech (HangZhou) Inc.
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- May 31, 2026
- Completion date
- June 30, 2030
- Enrollment
- 55 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
native right ventricle outflow tract(rvot) dysfunction